These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7615799)

  • 21. Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.
    Pichurin P; Aliesky H; Chen CR; Nagayama Y; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2003 Dec; 134(3):396-402. PubMed ID: 14632743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.
    Kita-Furuyama M; Nagayama Y; Pichurin P; McLachlan SM; Rapoport B; Eguchi K
    Clin Exp Immunol; 2003 Feb; 131(2):234-40. PubMed ID: 12562382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
    Aust G; Lehmann I; Heberling HJ
    Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by a recombinant human autoantibody Fab converted to IgE.
    Guo J; Quaratino S; Jaume JC; Costante G; Londei M; McLachlan SM; Rapoport B
    J Immunol Methods; 1996 Sep; 195(1-2):81-92. PubMed ID: 8814323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between the mannose receptor and thyroid autoantigens.
    Chazenbalk GD; Pichurin PN; Guo J; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2005 Feb; 139(2):216-24. PubMed ID: 15654820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight into Graves' hyperthyroidism from animal models.
    McLachlan SM; Nagayama Y; Rapoport B
    Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do heat shock proteins play a role in Graves' disease? Heat shock protein-specific T-cells from Graves' disease thyroids do not recognize thyroid epithelial cells.
    Trieb K; Sztankay A; Hermann M; Gratzl R; Szabo J; Jindal S; Grubeck-Loebenstein B
    J Clin Endocrinol Metab; 1993 Aug; 77(2):528-35. PubMed ID: 8345059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mouse model of Graves' disease: implications for a role of aberrant MHC class II expression in its pathogenesis.
    Shimojo N; Arima T; Yamaguchi K; Kikuoka S; Kohn LD; Kohno Y
    Int Rev Immunol; 2000; 19(6):619-31. PubMed ID: 11129118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease.
    Côté-Bigras S; Dionne A; Asselin-Mullen P; Leblicq C; Rottembourg D
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):296-300. PubMed ID: 23734883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
    Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
    Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
    Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
    J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of thyroid peroxidase in EBV-transformed B cell lines using adenovirus.
    Hidaka Y; Hayashi Y; Fisfalen ME; Suzuki S; Takeda T; Refetoff S; DeGroot LJ
    Thyroid; 1996 Feb; 6(1):23-8. PubMed ID: 8777380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease.
    Fisfalen ME; DeGroot LJ; Quintans J; Franklin WA; Soltani K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):776-84. PubMed ID: 3257970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A; Stasiak-Barmuta A; Urban M
    Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry.
    Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Dadan J
    Autoimmunity; 2005 Dec; 38(8):605-11. PubMed ID: 16390813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
    Nanba T; Watanabe M; Inoue N; Iwatani Y
    Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
    Kuang M; Wang S; Wu M; Ning G; Yao Z; Li L
    Mol Cell Endocrinol; 2010 May; 319(1-2):23-9. PubMed ID: 20015465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.